Samsara Therapeutics Inc.

Biotechnology company · Lewes, Delaware, United States

Samsara Therapeutics Inc. is a biotechnology company headquartered in Lewes, Delaware, United States. Its earliest recorded incorporation is in 2018. It has reported private securities offerings to the US SEC, most recently $10 million sold in a notice filed in 2021.

Profile compiled from public records. Is this your company? Request a correction or update

Samsara Therapeutics at a glance

Typebiotechnology company
HeadquartersLewes, Delaware, United States
Earliest incorporation on record2018
SEC CIK1872991

What does Samsara Therapeutics do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $10.3 million sold (2021).

Frequently asked questions about Samsara Therapeutics

Where is Samsara Therapeutics headquartered?

Samsara Therapeutics Inc. is headquartered in Lewes, Delaware, United States.

What does Samsara Therapeutics do?

Samsara Therapeutics Inc. is a biotechnology company.

When was Samsara Therapeutics founded?

The earliest incorporation on record for Samsara Therapeutics Inc. is in 2018, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences